CUDC-101

7-[[4-(3-乙炔基苯基氨基)-7-甲氧基喹唑啉-6-基]氧基]-N-羟基庚酰胺

CUDC101;CUDC 101;CURIS;7-[[4-(3-乙炔基苯基氨基)-7-甲氧基喹唑啉-6-基]氧基]-N-羟基庚酰胺

PF 670462

4-[1-环己基-4-(4-氟苯基)-1H-咪唑-5-基]-2-嘧啶胺盐酸盐

4-[1-环己基-4-(4-氟苯基)-1H-咪唑-5-基]-2-嘧啶胺盐酸盐;PF 67046;CS-318

KW-2478

KW-2478

KW-2478;2-Ethyl-3,5-dihydroxy-N,N-bis(2-methoxyethyl)-6-[3-methoxy-4-[2-(4-morpholinyl)ethoxy]benzoyl]benzeneacetamide;2-[2-ethyl-3,5-dihydroxy-6-[3-methoxy-4-(2-morpholin-4-ylethoxy)benzoyl]phenyl]-N,N-bis(2-methoxyethyl)acetamide;2-(2-ethyl-3,5-dihydroxy-6-(3-methoxy-4-(2-morpholinoethoxy)benzoyl)phenyl)-N,N-bis(2-methoxyethyl)acetamide;2-Ethyl-3,5-dihydroxy-N,N-bis(2-methoxyethyl)-6-[3-methoxy-4-[2-(4-morpholinyl)ethoxy]benzoyl]benzeneacetamide KW2478;2-(2-Ethyl-3,5-dihydroxy-6-(3-methoxy-4-(2-morpholinoethoxy)benzoyl)phenyl)-N,N-bis(2-methoxye

MK-2206 di hydrochloride

MK-2206 2HCl

8-[4-(1-氨基环丁基)苯基]-9-苯基-1,2,4-三...;MK-2206 2HCL;MK2206;CS-260;MK 2206 2HCL;MK2206 2HCL;MK-2206 DIHYDROCHLORIDE;MK2206 DIHYDROCHLORIDE;(8-[4-(1-氨基环丁基)苯基]-9-苯基-2H-[1,4]三唑并[3,4-F][1,6]萘啶-3-酮)二盐酸盐;MK-2206 二盐酸盐,一种变构 AKT 抑制剂;MK 2206 2HCL;MK2206 2HCL;8-[4-(1-氨基环丁基)苯基]-9-苯基-1,4-三唑并[3,6]萘啶-3(2H)-酮二盐酸盐

ADX-47273

(S)-(4-氟苯基)-{3-[3-(4-氟苯基)-[1,2,4]二唑-5-基]哌啶-1-基}甲酮

(S)-(4-氟苯基)-3-[3-(4-氟苯基)-[1,2,4]二唑-5-基]哌啶-1-基甲酮>98%;(S)-(4-氟苯基)-{3-[3-(4-氟苯基)-[1,4]二唑-5-基]哌啶-1-基}甲酮;CS-221;ADX-47273;ADX47273;(4-氟苯基)[(3S)-3-[3-(4-氟苯基)-1,4-噁二唑-5-基]-1-哌啶基]-甲酮

AMG 208

AMG 208

AMG208;AMG 208;CS-191;7-甲氧基-4-[(6-苯基-1,2,4-三唑并[4,3-B]哒嗪-3-基)甲氧基]喹啉;AMG-208;AMG208;AMG 208

PKI-402

PKI-402

PKI-402;1-[4-[3-乙基-7-(吗啉-4-基)-3H-[1,2,3]三唑并[4,5-D]嘧啶-5-基]苯基]-3-[4-[(4-甲基哌嗪-1-基)羰基]苯基]脲;PKI-402;PKI402

(Z)-but-2-enedioic acid,cyclopropyl-[4-[3-(1H-imidazol-5-yl)propoxy]phenyl]methanone

环丙基[4-[3-(1H-咪唑-4-基)丙氧基]苯基]甲酮马来酸盐

FUB 359 MALEATE;FUB359 MALEATE;FUB-359 MALEATE;CS-109;马来酸盐形式;CIPROXIFAN 马来酸盐;环丙基[4-[3-(1H-咪唑-4-基)丙氧基]苯基]甲酮马来酸盐

LY2109761

LY2109761

4-[5,6-二氢-2-(2-吡啶基)-4H-吡咯并[1,2-B]吡唑-3-基]-7-[2-(4-吗啉基)乙氧基]喹啉;N-CYCLOPENTYL-Β-ALANINE;4-[5,6-二氢-2-(2-吡啶)-4H-吡咯并[1,2-B]吡唑-3-基]-7-[2-(4-吗啉)乙氧基]喹啉;LY2109761,一种新型的,选择性TGF-Β RECEPTOR TYPE I;II (TΒRI;II)双重抑制剂;CS-101

AS-605240

5-(6-喹喔啉亚甲基)-2,4-噻唑啉二酮

5-(6-喹噁啉YL亚甲基)-2,4-噻唑烷二酮;4-噻唑啉二酮;5-(6-喹喔啉亚甲基)-2;AS-605240,一种特异的 PI3KΓ 抑制剂;5-(6-喹喔啉亚甲基)-2,4-噻唑啉二酮

Nitisinone

尼替西农

尼替西农杂质;NTBC;NITISONE;SC0735;ORFADIN;CS-99;尼替西农;2-(2-硝基-4-三氟甲基苯甲酰基)-1,4-环己二酮

AZ628

AZ 628

AZ-628;CAS 878739-06-1;AZ 628;AZ628;CS-70;3-(1-氰基-1-甲基乙基)-N-[3-[(3,4-二氢-3-甲基-4-氧代-6-喹唑啉基)氨基]-4-甲基苯基]苯甲酰胺

LY315920 (Varespladib)

伐瑞拉迪

伐瑞拉迪;CS-68;CS-2393;伐瑞拉迪>98%;伐瑞拉地

LY335979 (Zosuquidar tri hydrochloride)

唑喹达三盐酸盐

RS-33295-198;ZOSUQUIDAR;LY-335979;CS-58;唑喹达三盐酸盐;ZOSUQUIDAR 三盐酸盐;(2R)-1-{4-[(1AR,6R,10BS)-1,1-二氟-1,1A,6,10B-四氢二苯并[A,E]环丙并[C]环庚烯-6-基]哌嗪-1-基}-3-(喹啉-5-基氧基)丙-2-醇三盐酸盐;RS-33295-198,ZOSUQUIDAR;唑喹达盐酸盐

YM155

4,9-二氢-1-(2-甲氧基乙基)-2-甲基-4,9-二氧代-3-(2-吡嗪甲基)-1H-萘并[2,3-D]咪唑溴化物

4,9-二氢-1-(2-甲氧基乙基)-2-甲基-4,9-二氧代-3-(2-吡嗪甲基)-1H-萘并[2,3-D]咪唑溴化物;YM-155;YM 155;CS-35;YM155 (SEPANTRONIUM BROMIDE);YM-155;YM155,一种新型小分子存活素抑制剂

ADL5859 Hydrochloride

N,N-二乙基-4-(5-羟基螺[2H-1-苯并吡喃-2,4'-哌啶]-4-基)苯甲酰胺盐酸盐

ADL 5859;ADL-5859;CS-24;N,N-二乙基-4-(5-羟基螺[2H-1-苯并吡喃-2,4'-哌啶]-4-基)苯甲酰胺盐酸盐;ADL5859 HCL;ADL5859;ADL 5859

AZD4547

AZD-4547

REL-N-[5-[2-(3,5-二甲氧基苯基)乙基]-1H-吡唑-3-基]-4-[(3R,5S)-3,5-二甲基-1-哌嗪基]苯甲酰胺

LY2157299

LY 2157299

CS-5;LY-2157299;LY 2157299;4-[5,6-二氢-2-(6-甲基-2-吡啶基)-4H-吡咯并[1,2-B]吡唑-3-基]-6-喹啉甲酰胺;GALUNISERTIB;4-[5,2-B]吡唑-3-基]-6-喹啉甲酰胺(LY2157299);LY-2157299;LY 2157299;GALUNISERTIB;GALUNISERTIB,一种有效的TGF-Β RECEPTOR I (TΒRI)抑制剂

PI-103

PI-103

3-[4-吗啉-4-基吡啶并[3',2':4,5]呋喃并[3,2-D]嘧啶-2-基]苯酚;PI 3-激酶抑制剂;PI 3-激酶抑制剂 (PI-103);3-[4-(4-吗啉基吡啶并[3',2',4,2-D]嘧啶-2-基]苯酚;PI-103;PI 103;3-[4-(4-吗啉基吡啶并[3',2-D]嘧啶-2-基]苯酚盐酸盐;PI 103 盐酸盐;PI-103,一种有效地PI3K;AKT AND MTOR抑制剂